PriceTargets.com logo

Tempus AI - TEM Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $81.17
  • Forecasted Upside: 6.34%
  • Number of Analysts: 15
  • Breakdown:
  • 1 Sell Ratings
  • 7 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$76.33 As of 12/4/2025 05:00 PM ET
▲ +1.42 (1.90%)

This chart shows the closing price for TEM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Tempus AI Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TEM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TEM

Analyst Price Target is $81.17
▲ +6.34% Upside Potential
This price target is based on 15 analysts offering 12 month price targets for Tempus AI in the last 3 months. The average price target is $81.17, with a high forecast of $105.00 and a low forecast of $52.00. The average price target represents a 6.34% upside from the last price of $76.33.

This chart shows the closing price for TEM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 15 polled investment analysts is to hold stock in Tempus AI. This rating has held steady since September 2025, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 9 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 8 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 7 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 7 buy ratings
  • 6 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 7 buy ratings
  • 8 hold ratings
  • 1 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 7 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 7 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/1/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$80.00 ➝ $85.00
11/25/2025BTIG ResearchBoost TargetBuy ➝ Buy$96.00 ➝ $105.00
11/11/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$68.00 ➝ $80.00
11/11/2025Piper SandlerLower TargetNeutral ➝ Neutral$105.00 ➝ $80.00
11/7/2025HC WainwrightLower TargetBuy ➝ Buy$98.00 ➝ $89.00
11/5/2025Canaccord Genuity GroupLower TargetBuy ➝ Buy$110.00 ➝ $95.00
11/5/2025BTIG ResearchReiterated RatingBuy ➝ Buy$96.00
11/5/2025Needham & Company LLCBoost TargetBuy ➝ Buy$70.00 ➝ $100.00
10/22/2025Piper SandlerBoost TargetNeutral ➝ Neutral$70.00 ➝ $105.00
10/22/2025BTIG ResearchBoost TargetBuy ➝ Buy$85.00 ➝ $96.00
10/21/2025CowenDowngradeBuy ➝ Hold
10/21/2025TD CowenDowngradeBuy ➝ Hold$88.00
10/20/2025Canaccord Genuity GroupInitiated CoverageBuy$110.00
10/20/2025Canaccord Genuity GroupInitiated CoverageBuy$110.00
10/8/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
9/27/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
9/26/2025GuggenheimBoost TargetBuy ➝ Buy$80.00 ➝ $95.00
9/12/2025HC WainwrightBoost TargetBuy ➝ Buy$90.00 ➝ $98.00
9/2/2025HC WainwrightInitiated CoverageBuy$90.00
8/20/2025BTIG ResearchBoost TargetBuy ➝ Buy$75.00 ➝ $85.00
8/12/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$65.00 ➝ $68.00
8/8/2025BTIG ResearchInitiated CoverageBuy ➝ Buy$60.00
8/8/2025Piper SandlerReiterated RatingNeutral ➝ Neutral
8/8/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$70.00
6/30/2025GuggenheimBoost TargetBuy ➝ Buy$65.00 ➝ $75.00
6/25/2025Bank of AmericaBoost TargetNeutral ➝ Neutral$68.00 ➝ $70.00
5/20/2025Bank of AmericaBoost TargetNeutral ➝ Neutral$48.00 ➝ $68.00
5/15/2025Piper SandlerBoost TargetNeutral ➝ Neutral$55.00 ➝ $70.00
5/9/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$60.00 ➝ $65.00
5/7/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$70.00 ➝ $70.00
4/24/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$70.00 ➝ $70.00
4/21/2025BTIG ResearchInitiated CoverageBuy ➝ Buy$60.00
4/10/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$70.00 ➝ $70.00
3/6/2025Morgan StanleyBoost TargetOverweight ➝ Overweight$50.00 ➝ $60.00
3/4/2025Piper SandlerLower TargetNeutral ➝ Neutral$70.00 ➝ $55.00
3/3/2025Bank of AmericaBoost TargetNeutral ➝ Neutral$54.00 ➝ $60.00
2/26/2025Wolfe ResearchDowngradeStrong-Buy ➝ Hold
2/25/2025William BlairReiterated RatingMarket Perform
2/25/2025GuggenheimReiterated RatingBuy ➝ Buy
2/25/2025Needham & Company LLCBoost TargetBuy ➝ Buy$56.00 ➝ $70.00
2/25/2025JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$50.00 ➝ $55.00
2/12/2025William BlairDowngradeOutperform ➝ Market Perform
2/5/2025TD CowenReiterated RatingBuy$58.00 ➝ $74.00
1/14/2025Loop CapitalLower TargetBuy ➝ Buy$57.00 ➝ $52.00
1/14/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$56.00 ➝ $56.00
12/13/2024Bank of AmericaBoost TargetNeutral ➝ Neutral$52.00 ➝ $54.00
12/13/2024Wolfe ResearchInitiated CoverageOutperform$60.00
12/9/2024GuggenheimInitiated CoverageBuy$74.00
11/12/2024Piper SandlerReiterated RatingNeutral ➝ Neutral$40.00 ➝ $70.00
11/11/2024Stifel NicolausDowngradeBuy ➝ Hold$45.00 ➝ $65.00
10/15/2024Loop CapitalBoost TargetBuy ➝ Buy$48.00 ➝ $57.00
10/2/2024Bank of AmericaDowngradeBuy ➝ Neutral$45.00 ➝ $60.00
8/12/2024Piper SandlerInitiated CoverageNeutral$40.00
8/7/2024JPMorgan Chase & Co.Boost TargetOverweight ➝ Overweight$42.00 ➝ $47.00
8/7/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$47.00 ➝ $47.00
7/9/2024Bank of AmericaInitiated CoverageBuy$41.00
7/9/2024Longbow ResearchInitiated CoverageBuy$48.00
7/9/2024William BlairInitiated CoverageOutperform
7/9/2024Morgan StanleyInitiated CoverageOverweight$44.00
7/9/2024Stifel NicolausInitiated CoverageBuy$45.00
7/9/2024Needham & Company LLCInitiated CoverageBuy$47.00
7/9/2024TD CowenInitiated CoverageBuy$50.00
7/9/2024Loop CapitalInitiated CoverageBuy$48.00
7/9/2024JPMorgan Chase & Co.Initiated CoverageOverweight$42.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

1.28 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 5 very positive mentions
  • 15 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 61 very positive mentions
  • 90 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
9/5/2025
  • 47 very positive mentions
  • 33 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
10/5/2025
  • 46 very positive mentions
  • 36 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 66 very positive mentions
  • 18 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 66 very positive mentions
  • 18 positive mentions
  • 3 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Tempus AI logo
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Read More

Today's Range

Now: $76.33
Low: $74.34
High: $78.09

50 Day Range

MA: $82.12
Low: $65.69
High: $103.25

52 Week Range

Now: $76.33
Low: $31.36
High: $104.32

Volume

3,635,907 shs

Average Volume

5,121,197 shs

Market Capitalization

$13.58 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

4.99

Frequently Asked Questions

What sell-side analysts currently cover shares of Tempus AI?

The following Wall Street analysts have issued research reports on Tempus AI in the last year: Bank of America Corporation, BTIG Research, Canaccord Genuity Group Inc., Cowen Inc, Guggenheim, HC Wainwright, JPMorgan Chase & Co., Loop Capital, Morgan Stanley, Needham & Company LLC, Piper Sandler, TD Cowen, Weiss Ratings, William Blair, and Wolfe Research.
View the latest analyst ratings for TEM.

What is the current price target for Tempus AI?

0 Wall Street analysts have set twelve-month price targets for Tempus AI in the last year. Their average twelve-month price target is $81.17, suggesting a possible upside of 6.3%. BTIG Research has the highest price target set, predicting TEM will reach $105.00 in the next twelve months. Loop Capital has the lowest price target set, forecasting a price of $52.00 for Tempus AI in the next year.
View the latest price targets for TEM.

What is the current consensus analyst rating for Tempus AI?

Tempus AI currently has 1 sell rating, 7 hold ratings and 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in TEM, but not buy more shares or sell existing shares.
View the latest ratings for TEM.

What other companies compete with Tempus AI?

Other companies that are similar to Tempus AI include Electronic Arts, Baidu, Atlassian, Block and Veeva Systems. Learn More about companies similar to Tempus AI.

How do I contact Tempus AI's investor relations team?

Tempus AI's physical mailing address is 600 WEST CHICAGO AVENUE SUITE 510, CHICAGO IL, 60654. The company's listed phone number is 800-976-5448 and its investor relations email address is [email protected]. The official website for Tempus AI is www.tempus.com. Learn More about contacing Tempus AI investor relations.